1. Home
  2. METCB vs PHAR Comparison

METCB vs PHAR Comparison

Compare METCB & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ramaco Resources Inc. Class B

METCB

Ramaco Resources Inc. Class B

HOLD

Current Price

$11.88

Market Cap

727.7M

Sector

Energy

ML Signal

HOLD

Logo Pharming Group N.V.

PHAR

Pharming Group N.V.

HOLD

Current Price

$16.94

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
METCB
PHAR
Founded
2015
1988
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Coal Mining
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
727.7M
1.1B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
METCB
PHAR
Price
$11.88
$16.94
Analyst Decision
Buy
Strong Buy
Analyst Count
8
2
Target Price
$38.69
$38.00
AVG Volume (30 Days)
94.9K
26.0K
Earning Date
10-27-2025
11-06-2025
Dividend Yield
3.11%
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.00
Revenue
$579,503,000.00
$362,274,000.00
Revenue This Year
N/A
$25.19
Revenue Next Year
$19.85
$4.47
P/E Ratio
N/A
$3,014.62
Revenue Growth
N/A
26.78
52 Week Low
$5.86
$7.50
52 Week High
$21.80
$18.30

Technical Indicators

Market Signals
Indicator
METCB
PHAR
Relative Strength Index (RSI) 49.53 50.89
Support Level $10.50 $16.55
Resistance Level $12.25 $18.30
Average True Range (ATR) 0.81 0.76
MACD 0.22 -0.06
Stochastic Oscillator 72.30 36.83

Price Performance

Historical Comparison
METCB
PHAR

About METCB Ramaco Resources Inc. Class B

Ramaco Resources Inc is a United States-based company that operates as a pure-play metallurgical coal company with operations in southern West Virginia and southwestern Virginia. Its portfolio includes high-quality metallurgical coal reserves & resources, with a focus on properties such as Elk Creek, Berwind, Knox Creek, and Maben. These properties are strategically located to serve North American blast furnace steel mills and coke plants, as well as international metallurgical coal consumers. Additionally, the company controls mineral deposits in Sheridan, Wyoming, exploring potential opportunities in rare earth elements and coal-to-carbon-based products. Operations are concentrated in the Appalachian basin, with active mines at Elk Creek, Berwind, Knox Creek, and Maben mining complexes.

About PHAR Pharming Group N.V.

Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.

Share on Social Networks: